Try our Advanced Search for more refined results
Life Sciences - July, 2006
121 articles
- Boston Scientific, St. Jude Settle Four Patent Suits
- ImClone Motion Denied In Erbitux Case
- FTC Probes Mylan Over Provigil Settlements
- Smith & Nephew Blames Sales Rep In Antitrust Probe
- Digene Wins Arbitration Ruling Over HPV License
- In Reversal, FDA Opens Door To Morning-After Pill
- State Attorneys General Reject Revised Plavix Deal
- FDA Breast Implant Decisions Cleared By Senate Panel
- Pfizer Puts General Counsel In Charge
- Biomet Says DoJ Scales Down Antitrust Probe
- Trial Begins In Latest Wyeth Diet Drug Case
- Intermune Eyes Settlement Over Off-Label Marketing
- FBI Raids Bristol-Myers Over Plavix Deal
- SEC Settles Case Over Insider Trading On FDA Decision
- SEC Adds Defendants To Insider-Trading Suit
- DOJ Launches Criminal Probe Into Plavix Deal
- Abbott Wins Antitrust Challenge Over HIV Drug Cocktail
- J&J Unit Takes On Wyeth's Effexor In Patent Suit
- Bill Would Move Vaccine Safety Out Of CDC
- Zimmer Tries To Clear Name In Price-Fixing Scandal
- Invitrogen Gets Biotech Patent Win In Jury Trial
- Korea Pushes Drug-Pricing Law
- Tyco Sticks Applied Medical With Fresh Patent Suit
- Judge Tosses Patent Case Against Stryker
- Universities, Hospitals Join Patent Litigation Bonanza
- Upsher-Smith, Unigene Sue Apotex After ANDA Filing
- Orthopedic Industry Braces For Possible Storm
- SEC Investigates Par Pharmaceutical
- Eye Care Company Says It's Not Eyeing Rival's Patent
- Jury Awards $5M In Infant Tylenol Poisoning Case
- FDA Bolsters Rules On Outside Advisors
- Plavix Ruling From Attorneys General Imminent
- Van Der Moolen Washes Its Hands Of Stock Fraud
- Swiss University Sues Synthes In Pilot Case
- RxUSA Files New Suit Against Wholeseller
- N.J. High Court Mulls Vioxx Class Status; $30B At Stake
- America's Top Health Litigators: Drinker Biddle & Reath
- Early Approval For Astra's Asthma Drug Stuns Analysts
- America's Top Health Litigators: Reed Smith
- Amgen Criticizes Roche's Anemia Study
- Orthopedic Company Antitrust Subpoena "Narrowed"
- Par Pharmaceutical Hit With Securities Suits
- Roche Rallies In Wake Of Enzo Biochem Ruling
- Senators Take Aim At Authorized Generics
- Erbitux Trial Awaits Judge's Decision
- Brinks Hofer Opens Doors In Salt Lake City
- Political Pressure-Cooker Mentality At FDA: Report
- Elan Files Patent Suit Over Breast Cancer Drug
- UBS Says Bankrupt Company Is Overvalued By $100M
- America's Top Health Litigators: McDermott Will & Emery
- ImClone, Merck Reach Deal Over Erbitux
- Suit Alleges Conspiracy Among Drug Cos., Wholesalers
- FTC Commissioner Slams Authorized Generics
- Court Finds Non-Infringement In Alaris, ICU Case
- America's Top Health Litigators: Sidley Austin
- Fed. Circuit Affirms University's Grip On Allergy Patent
- E-mails Question FDA Review Process For Ketek
- Court Issues Markman Ruling In Enzo Biochem Case
- Fourth Circuit Rejects Another Authorized Generics Challenge
- FDA OKs Medtronic's New Glucose Monitor
- Court Upholds Blood Pressure Drug Patent
- Jury Denies Baxter's $87M Bid In Dialysis Dispute
- Settlement Gets To Heart Of Stent Lawsuit
- Six Years After Wyeth Debacle, Birth Control Rod OK'd
- Medtronic To Pay $40M To Settle Kickback Charges
- America's Top Health Litigators: Jones Day
- Bio-Rad Settles Lengthy Licensing Dispute
- Generic Drug Maker Gets Chapter 11 OK
- America's Top Health Litigators: Fitzpatrick, Cella
- Eli Lilly Gets Green Light For New Use Of Gemzar
- Royal Bank Of Scotland Nearing Enron Settlement
- FDA Opts To Fast Track Constipation Drug
- Roche, Sanofi Settle Australian Vitamins Cartel Action
- Pfizer Stuck With 17 New Lipitor Suits
- Ex-Van Der Moolen Specialists Convicted Of Fraud
- Orthopedic Makers Conspired To Fix Prices, Suit Claims
- America's Top Health Litigators: McCarter & English
- Class Action Adds To Drug Maker's Troubles
- Lawmakers Try To Put Brakes On Medicare Overhaul
- In Blow To Ivax, Judge Upholds Lexapro Patent
- FDA Calls Off Closed Hearing On Blood Substitute
- Tax Patents: Ball Is In Your Court, PTO Tells Congress
- Health Courts? No Thanks, Say Trial Lawyers
- America's Top Health Litigators: Kaye Scholer
- British Enron Trio Depart For Texas Trial
- New Study Supports Biotech Fears Over USPTO Changes
- Law Firm Profile: Banner & Witcoff Ltd.
- FDA Draws Fire For Closed Hearing On Blood Substitute
- Merck Wins New Jersey Vioxx Case
- Generic Drug Settlement Prompts More FTC Scrutiny
- SeraCare, Shareholders Agree To Exclusivity Deal
- FDA Backs Boston Scientific's Recall Of Heart Devices
- Merck Strategy Still Murky As Jury Mulls Vioxx Claims
- America's Top Health Litigators: Shook, Hardy & Bacon
- Senate Votes To Allow Access To Canadian Drugs
- Judge Tosses Sandoz' Injunctive Bid Over Zocor
- Dusa Targets Chemical Supplier, Physicians In Suits
- Lawyer: Heart Attack Caused By Bad Health, Not Vioxx
- FDA Slacking On Post-Approval Follow-Up: Report
- America's Top Health Litigators: Dechert
- Forest Sues To Keep Generic Lexapro Off Market
- Lawmakers Debate NatWest Three Extradition
- Medegen Unit Hits ICU Medical With Suit
- FTC Scrutiny Casts Doubt On Plavix Settlement
- Chemical Cos. Settle Spat Over Cystic Fibrosis Drug
- Under Vioxx Fire, Merck Faces Fosamax Claims Too
- Lord Bissell's Health Care Practice Balloons
- As Drug Risks Mount, Senators Put Pressure On FDA
- Lawsuit Targets Director Of USPTO
- 10 Stand-Out Firms Win Industry's Confidence
- Amgen Loses Battle In Anemia War With La Roche
- Extradition Day Arrives For U.K. Bankers
- University, Nektar Settle Patent Feud For $25M
- J&J Subsidiaries Fight Back Generic Challenge
- FTC Detects Cancer Screening Monopoly
- Citizen Petitions Come Under Fire In Pharma War
- Ruling Sets Up Patent Battle Over Growth Treatment
- Device Makers Settle Suit Over Incontinence Treatment
- Doctor Testifies Merck Knew Of Vioxx Risk
- British Business Leaders Brassed Off Over Extradition
- The Gathering Storm: Supreme Court Case Promises Change in Patent Law